Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VAXZEVRIA Intramuscular Injection General Use Result Study for the Long-term Safety of VAXZEVRIA

NCT05135455 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05135455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VAXZEVRIA Intramuscular Injection General Use Result Study for the Long-term Safety of VAXZEVRIA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 21, 2022
Completion date
August 31, 2023
Enrollment
467 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of infectious disease caused by sars-cov-2